Preparation and characterization of amylose-pyrazinamide inclusion complexes

A. C. Ribeiro, L. Fonseca, R. Soares, N. D. da Silveira, G. L. Peres
{"title":"Preparation and characterization of amylose-pyrazinamide inclusion complexes","authors":"A. C. Ribeiro, L. Fonseca, R. Soares, N. D. da Silveira, G. L. Peres","doi":"10.1109/ENBENG.2015.7088808","DOIUrl":null,"url":null,"abstract":"Amylose is a linear polymer composed almost entirely of α-1,4-linked units. This biopolymer tends to form single helical inclusion complexes with suitable agents. The study of these complexes presents a great interest since the guest molecules that have been trapped at some stage can be release later, thus leading to many applications, especially in the pharmaceutical and food industry. Amylose is considered as a promising carrier biomaterial of prodrugs [1]. Pyrazinamide (PZA) has long been recognized as an active drug against Mycobacterium tuberculosis, however the administration of PZA in high dosage can cause bacterial resistance. Therefore there is a need for new methodologies which would reduce the administration time and improve therapeutic effect of PZA [2]. The aim of our study was to characterize the amylose-PZA complex. The inclusion complex was prepared by acidification of an alkali solution. Formation and characterization (particle size) of the inclusion complexes in solution were characterized by dynamic light scattering and UV spectroscopy. As the complexation causes changes in the absorption spectrum of a guest molecule, change in the colour of the solution from yellow to colourless was noticed. Furthermore, differences in intensity of the bands, and a slight shift of the absorption spectrum of inclusion complexes, in comparison with the pure amylose solution were observed. The UV analyses confirmed the formation of the amylose-PZA inclusion complexes. DLS analysis has been made for: complexes with pure amylose (without PZA), with PZA (without amylose) and amylose-PZA complexes. The amylose particle size, without the guest molecule, was (101,16±2,60) nm and its relative average poly dispersity index was 0,41±0,04. For the PZA particle the size was (223,70±13,76) nm and its relative average polydispersity index was 0,27±0,10. On the other hand for the amylose-PZA inclusion complexes the size (81,11±1,43) nm was observed and its relative average polydispersity index was 0,26±0,02. As can be seen the size of the complex is smaller than of the pure amylose or PZA particle in solution. This can be attributed to the presence of PZA that induces hydrophobic interactions resulting in the contraction of the complexes and providing a relatively hydrophilic surface. Furthermore, PDI results also indicated that sizes generated from inclusion complexes have a narrow size distribution. Thus, new analysis tests will be conducted to provide more information about structure and morphology of inclusion complexes.","PeriodicalId":285567,"journal":{"name":"2015 IEEE 4th Portuguese Meeting on Bioengineering (ENBENG)","volume":"2014 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2015 IEEE 4th Portuguese Meeting on Bioengineering (ENBENG)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ENBENG.2015.7088808","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Amylose is a linear polymer composed almost entirely of α-1,4-linked units. This biopolymer tends to form single helical inclusion complexes with suitable agents. The study of these complexes presents a great interest since the guest molecules that have been trapped at some stage can be release later, thus leading to many applications, especially in the pharmaceutical and food industry. Amylose is considered as a promising carrier biomaterial of prodrugs [1]. Pyrazinamide (PZA) has long been recognized as an active drug against Mycobacterium tuberculosis, however the administration of PZA in high dosage can cause bacterial resistance. Therefore there is a need for new methodologies which would reduce the administration time and improve therapeutic effect of PZA [2]. The aim of our study was to characterize the amylose-PZA complex. The inclusion complex was prepared by acidification of an alkali solution. Formation and characterization (particle size) of the inclusion complexes in solution were characterized by dynamic light scattering and UV spectroscopy. As the complexation causes changes in the absorption spectrum of a guest molecule, change in the colour of the solution from yellow to colourless was noticed. Furthermore, differences in intensity of the bands, and a slight shift of the absorption spectrum of inclusion complexes, in comparison with the pure amylose solution were observed. The UV analyses confirmed the formation of the amylose-PZA inclusion complexes. DLS analysis has been made for: complexes with pure amylose (without PZA), with PZA (without amylose) and amylose-PZA complexes. The amylose particle size, without the guest molecule, was (101,16±2,60) nm and its relative average poly dispersity index was 0,41±0,04. For the PZA particle the size was (223,70±13,76) nm and its relative average polydispersity index was 0,27±0,10. On the other hand for the amylose-PZA inclusion complexes the size (81,11±1,43) nm was observed and its relative average polydispersity index was 0,26±0,02. As can be seen the size of the complex is smaller than of the pure amylose or PZA particle in solution. This can be attributed to the presence of PZA that induces hydrophobic interactions resulting in the contraction of the complexes and providing a relatively hydrophilic surface. Furthermore, PDI results also indicated that sizes generated from inclusion complexes have a narrow size distribution. Thus, new analysis tests will be conducted to provide more information about structure and morphology of inclusion complexes.
直链淀粉-吡嗪酰胺包合物的制备与表征
直链淀粉是一种几乎完全由α-1,4连接单元组成的线性聚合物。这种生物聚合物倾向于与合适的试剂形成单螺旋包合物。这些复合物的研究引起了人们极大的兴趣,因为在某个阶段被捕获的客体分子可以在稍后释放,从而导致许多应用,特别是在制药和食品工业中。直链淀粉被认为是一种很有前途的前药载体生物材料[1]。吡嗪酰胺(Pyrazinamide, PZA)长期以来被认为是抗结核分枝杆菌的有效药物,但大剂量给药会引起细菌耐药。因此,需要新的方法来缩短给药时间,提高PZA的治疗效果[2]。我们研究的目的是表征直链淀粉- pza复合物。采用碱溶液酸化法制备包合物。采用动态光散射和紫外光谱对溶液中包合物的形成和表征(粒径)进行了表征。由于络合作用引起客体分子吸收光谱的变化,因此注意到溶液的颜色从黄色变为无色。此外,还观察到与纯直链淀粉溶液相比,包合物的吸收光谱强度存在差异,并且有轻微的偏移。紫外分析证实了直链淀粉- pza包合物的形成。DLS分析包括:纯直链淀粉配合物(不含PZA)、含PZA配合物(不含直链淀粉)和直链淀粉-PZA配合物。不含客体分子的直链淀粉粒径为(101,16±2,60)nm,相对平均多分散指数为0,41±0,04。PZA颗粒粒径为(223,70±13,76)nm,相对平均多分散性指数为0.27±0.10。直链淀粉- pza包合物粒径为(81,11±1,43)nm,相对平均多分散性指数为0.26±0.02。可以看出,复合物的大小比溶液中的纯直链淀粉或PZA颗粒小。这可以归因于PZA的存在,它诱导疏水相互作用,导致复合物收缩并提供相对亲水的表面。此外,PDI结果还表明,包合物生成的粒径分布较窄。因此,将进行新的分析测试,以提供有关包合物结构和形态的更多信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信